Abstract
The co-occurrence between migraine and vertigo has been noticed for a long time ago. In recent years, however, growing numbers of epidemiological and clinical studies have definitely shown the significant relation between these two diseases. Recently, the term “vestibular migraine” is used commonly in studies. Vestibular migraine has taken place in appendix in the latest International Headache Society Classification. In this review, epidemiology, clinical features, diagnostic criteria and treatment of vesti-bular migraine will be discussed.
Keywords: Vestibular migraine, vertigo, migraine, migraine with aura
ÖZET
Migren ve vertigo birlikteliği uzun zamandır bilinmektedir. Ancak son yıllarda artan sayıda klinik ve epidemiyolojik çalışmada migren ve vertigo arasındaki anlamlı bağlantı net olarak gösterilmiştir. Vestibüler migren adı çalışmalarda ortak olarak kullanılmaya başlamıştır. Uluslararası başağrısı sınıflamasında appendikste yer almıştır. Bu derlemede vestibüler migrenin epidemiyolojisi, klinik özellikleri, tanı kriterleri ve tedavisinden bahsedilecektir.
Introduction
Liveing pointed out the association of recurrent vertigo attacks and migraine in the 19th century. The subject came to the fore again after publication of the article of Kayan and Hood titled “neurootological symptoms of migraine” (1). In this study, it was reported that neuro-otological disorders accompanied migraine in 77% of the patients with migraine (1). The association of migraine and vertigo was emphasized in the following studies (2, 3). There were also clues about the linkage between migraine and vertigo before the studies pointing out the association of migraine and vertigo. Benign paroxismal vertigo of childhood and benign recurrent vertigo of adults are well-known equivalents of migraine. Benign paroxismal vertigo of childhood is a picture characterized with imbalance attacks, anxiety and frequently nistagmus and vomiting (4). It is observed in healthy children as a recurrent picture. It was shown that migraine developed in these children after vertigo attacks ended (5). When compared with controls, migraine is observed with a 2-fold higher frequency in the first-degree relatives of these children (6). Benign recurrent vertigo of adults is triggered with sleeplessness and emotional stress and is observed more frequently in women. There is a history of migraine in these patients and their families. This disorder shows some common characteristics with migraine (7). In fact, this clinical picture can be considered vestibular migraine in the light of our new information.
Recent epidemiological studies have shown that the assocaition of migraine and vertigo is not accidental (8). Although clinical and epidemiological studies have shown the association of migraine and vertigo undoubtedly, it has not been included in the classification of headache until recently, since it has not attracted the attention of the International Headache Society. As a result of the explosion of publications on this subject in the last ten years, it has been included in the appendix of the classification published recently (9). One of the reasons of this is the fact that migraine patients with dizziness are examined by neurologists, neuro-otologists of otolargynology origin, emergency physicians and general practitioners and there is failure of evaluation of these patients for the complaints of vertigo and dizziness by the physicians who are interested in headache and migraine. Although different names including migrainerelated dizziness (10,11), migraine-related vestibulopathy (12,13), vestibular migraine (3) and migraineous vertigo (14) were given to the association of migraine and vertigo, “vestibular migraine” has started to be used in recent years.
In epidemiological studies, the prevalence of migraine in the adult population has been found to be 16% (15) and the prevalence of vertigo has been found to be 7% (16). Accordingly, accidental association of migraine and vertigo is expected in 1.1% of the general population. In a study performed by Neuhauser et al. in 2001, 200 patients who presented to the orthopaedic outpatient clinic and 200 patients who presented to the vertigo outpatient clinic were examined in terms of migraine and headache and the prevalence of migraine was found to be 38% in the patients who presented to the vertigo outpatient clinic and 24% in the patients who presented to the orthopaedic outpatient clinic (14). In addition, the same investigators conducted a population-based study in 2006 and found the prevalence of vestibular migraine to be 1% and the prevalence of association of vestibular vertigo and migraine to be 3.2% (17). This result is 3-fold higher than expected. It was observed that 87% of 208 patients with recurrent vertigo of unknown origin met the diagnostic criteria of migraine and it was reported that 70% of these patients met the definite diagnostic criteria of vestibular migraine (18). In a similar group of patients including a smaller number of patients, the prevalence of migraine was found to be 6-fold higher compared to the control group (19). It was reported that two other vestibular diseases including benign paroxismal positional vertigo (BPPV) and Meniére’s disease were epidemiologically related with migraine (20, 21). Diagnosis of vestibular migraine which has a prevalence of 1% and which leads to labour loss and loss of quality of life is considerably important. The investigators who conducted the above-mentioned epidemiological studies report that these conditions are recognized with a low rate even among physicians (8). In a patient presenting with a complaint of vertigo diagnosed with definite migraine or in a patient with headaches who has no diagnosis of migraine, verstibular migraine should be considered in the first order after BPPV which is the most common cause of vertigo is excluded. The diagnosis is made with the properties of history and exclusion of other causes. The definite and probable diagnostic criteria for vestibular migraine were proposed by Neuhauser et al and these criteria are being used frequently in studies (22).
Diagnostic criteria for definite vestibular migraine
Recurrent moderate or severe vertigo attacks
A diagnosis of migraine according to the 2004 classification of the International Headache Society
Accompaniment of at least one of migraineous headache, photophobia, phonophobia, visual and other auras to at least two vertigo attacks
Exclusion of the causes which may lead to this picture by appropriate investigations.
Diagnostic criteria for probable vestibular migraine:
Recurrent moderate or severe vertigo attacks
-
Presence of at least one of the following:
A diagnosis of migraine according to the 2004 classification of the International Headache Society
Accompaniment of migraineous symptom to at least two vertigo attacks
Accompaniment of migraine triggers to more than 50% of vertigo attacks before attacks: certain foods, sleep irregularities, hormonal changes
Response to migraine treatment in more than 50% of the attacks
Exclusion of the causes which may lead to this picture by appropriate investigations.
The same investigators reached the same diagnosis in patients whom they followed up for a mean period of 9 years and reevaluated according to the diagnostic criteria they proposed and in a way, retested the diagnostic criteria (23). Afterwards, the Bárány Organization published a new classification together with the International Headache Society Migraine Classification Subcommittee (9).
Accordingly, for a diagnosis of vestribular migraine
Five moderate and severe attacks lasting for 5 minutes-72 hours accompanied by vestibular symptoms
A diagnosis of migraine with or without aura according to the International Headache Society classification
-
Accompaniment of one of the following to at least 50% of the attacks:
Presence of headache meeting at least two of the followingunilateral localization, throbbing characteristic, moderate or severe pain, increase in severity with routine physical activity
Photophobia and phonophobia
Visual aura
Absence of a more clear vestibular diagnosis or an international headache classification diagnosis.
For a probable diagnosis of vestibular migraine: B in addition to A above-presence of only one of B and C criteria above (history of migraine or migraine characteristics during attack) C- the same as C above.
In the new classification of headache of the International Headache Society, only “vestibular migraine” is included in the appendix and “probable vestibular migraine” is not included. If Bárány and IHS classification is compared with Neuhauser classification, 2 attacks are required for a definite diagnosis in Neuhauser classification, while 5 attacks are required in the new classification. This may be thought to have restricted the diagnostic criteria. However, it should be considered a success that it was included in the final headache classification.
The diagnosis can only be made after a well taken history. Vestibular migraine can be observed at any age. It is more frequent in women. In most patients, migraine starts firstly. In some patients, it may be observed even years after migraine attacks end (22). The patients typically describe spontaneous or positional vertigo. Intolerability to head movements is present. Recurrent imbalance triggered or worsened with head movements are additional findings indicating a vestibular problem (22). The time period of vertigo may last from seconds to hours or sometimes to days. In 10–30% of the patients, vertigo lasts for 5–60 minutes as in typical migraine aura (3, 14). Headache may accompany in some attacks and may not accompany in some others. In some patients, headache never accompanies vertigo (10, 14). Photophobia, phonophobia, visual and other auras may accompany vertigo (22). Vertigo and dizziness may also be triggered by complex visual moving stimuli (12). Hearing loss and tinnitus are not observed frequently in vestibular migraine, but some cases with hearing loss and tinnitus have been reported (3, 12).
It is considerably difficult to make the diagnosis in patients who do not have a definite diagnosis of migraine. In patients who present with a complaint of vertigo, a detailed history about the complaint of headache should absolutely be taken. In our country, migraine is not a well-known disease; the patients are usually diagnosed with sinusitis. In each patient who presents to our balance outpatient clinic with vertigo and imbalance, we take a detailed history for headache. A positive familial history of migraine and a personal history of motion sickness are important clueas in favour of migraine, because motion sickness is a very frequent complaint in individuals with a history of migraine (24). In cases where one can not know for certain that the patient has headache, the “migraine ID” test can be used safely for a diagnosis of migraine. (24). The reliability of the migraine ID test has been tested in different studies (26, 27).
In two posturography studies performed in patients who had no vertigo or imbalance, it was shown that these patients had an imbalance problem compared to healthy controls. When the same patients and controls were evaluated after a mean time of 1,5 years with the same test battery in a second study, it was shown that the present moderate imbalance was progressed (28, 29). Knowing which patients with migraine have the potential to develop vestibular migraine may give significant clues for planning the diagnosis and treatment of these patients. With this objective, patients with vertigo/dizziness or motion sickness were divided into two groups as the ones “with migraine with vestibular symptoms” and the ones “without migraine with vestibular symptoms” in a study and their clinical properties were examined. It was found that the patients with these complaints showed different clinical properties compared to the other group and it was porposed that “migraine with vestibular symptoms” could be a subgroup of migraine (30). Accordingly, patients with “migraine with vestibular symptoms” seem to have a younger age, migraine with aura, a longer history of migraine, a higher monthly frequency of headache, complain of phonophobia with a higher rate, are affected by menstrual and seasonal changes with a higher rate, have a history of allergy and sleep irregularity with a higher rate and had had cyclic vomiting and recurrent abdominal pain in the childhood with a significantly higher rate.
The pathophysiology of vestibular migraine is not clear. Detection of central vestibular nistagmus in the acute phase suggests central vestibular dysfunction (31, 32). It is not known how migraine affects the vestibular system. It has been tried to be explained with different hypotheses. Vasospasm of the internal auditory artery may explain peripheral vestibular and auditory findings, association of migraine, BPPV and Meniere’s disease (33). Vertigo is the most common aura of basilar migraine and the clinical equivalent of extending depression (3). Extending depression has been thought to be the cause of short-term vertigo attacks in MV (3). Calcitonin gene-related peptide released during migraine attacks act on the peripheral and central vestibular structures and may lead to disruption in signal processing (10, 34). It has been proposed that ion channel disorders may be related with the pathophysiology of migraine. Migraine and vertigo are the most common complaints in familial hemiplegic migraine and episodic ataxia type 2 (EA2) which are paroxismal disorders and the cause is mutation in the calcium gene (35). Channelopathy may explain central and peripheral vestibular dysfunction and seems to be the best model to explain vestibular migraine (31). However, studies examining mutations on candidate genes have given negative results (36, 37).
In a patient who presents with a complaint of vertigo and who has a definite diagnosis of migraine or in a patients who has headaches and no diagnosis of migraine, the diagnosis of vestibular migraine should be considered after excluding BPPV which is the most common cause of vertigo. However, vestibular migraine may mimic non-vestibular psychiatric pictures where peripheral vestibular involvement (BPPV, Meniére’s disease), central vestibular involvement and “dizziness” occur. The differential diagnosis of Meniéres disease and vestibular migraine may be difficult especially in patients in whom hearing loss is not prominent in the initial phase. Tinnitus and aural fullness may accompany vestibular migraine attacks, but this is generally bilateral; it is unilateral in Meniére’s disease (12,38). Patients with unclear hearing loss should be follwed up with audiometric examination during attacks and outside attacks. Publications indicating the relation between migraine and Meniére’s disease have increased in recent years (21, 38, 39, 40). In a study which included 75 patients who were being followed up with a diagnosis of vestibular migraine, 10% of the patients were reported to meet both the definite diagnostic criteria of vestibular migraine and the diagnostic criteria of Meniere’s diseases (23). Although vestibular migraine and EA2 share common and clinical characteristics including a familial history of recurrent vertigo attacks, EA2 is a rare autosomal dominant picture which generally starts below the age of 20 (41). A relation between vertigo, “dizziness” and migraine and some psychiatric disorders has also been demonstrated (42).
Patients with vestibular migraine may describe psychogenic “dizziness” attacks which may be caused by some environmental factors other than recurrent vertigo attacks.
There is no proven treatment option in vestibular migraine. Primarily, the frequency of migraine attacks should be decreased. It should be explained that migraine triggers should be avoided and when the frequency of headaches decreases, the vertigo and imbalance attacks will also decrease. The patient should be informed that anything tirgerring migraine attack would also trigger vertigo attacks and migraine triggers should be explained. Since the attacks affect the quality of life of patients in vestibular migraine, prophylaxis should be considered. However, all the drugs used have different side effects. In our outpatient clinic where we examine balance disorders, we primarily talk with our patients with vestibular migraine on potential attack triggers and decide on prophylaxis after evaluating vertigo and headache charts of the patients in the next vizit. We observed that avoiding attack triggers (fasting, sleep irregularities, certain foods) and exercise controlled the attacks in many patients without a need for prophylaxis. If acute migraine attack lasts long (longer than 1–2 hours), short-term (2 days at most) dimenhydrinate may be used. Propranolol, metoprolol, tricyclic antidepressants, pizotifen, flunarizine, topiramate, valproic acid and lamotrigine which are used in prophylaxis of migraine have been reported to be efficient (43, 44). Appropriate prophylactic treatment should be decided together with the patient according to the life activity of the patient. In patients with a history of hypertension, propronalol may be selected primarily. In patients with sleep problems, tricyclic antidepressants may be preferred. It should be kept in mind that flunarizine may lead to movement disorders when used in patients above the age of 40 (45). Although it is recommended that triptans should not be used in basilar migraine, it has been proposed that triptans may be used in vestibular migraine (8). In a placebo-controlled randomized study, response to zolmitriptan was found with a rate of 38% and response to placebo was found with a rate of 22%, but these results were not found to be statistically significant (46). In patients with continuous “dizziness”, vestibular rehabilitation is recommended (13).
In summary, vestibular migraine is a very common clinical picture. To make the diagnosis, it should be considered primarily. It should be considered in each patient who presents with vertigo, since it is the second most common cause of vertigo.
Footnotes
Conflict of interest: The authors reported no conflict of interest related to this article
Çıkar çatışması: Yazarlar bu makale ile ilgili olarak herhangi bir çıkar çatışması bildirmemişlerdir
References
- 1.Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107:1123–1142. doi: 10.1093/brain/107.4.1123. [DOI] [PubMed] [Google Scholar]
- 2.Baloh RW. Neurotology of migraine. Headache. 1997;37:615–621. doi: 10.1046/j.1526-4610.1997.3710615.x. [DOI] [PubMed] [Google Scholar]
- 3.Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–892. doi: 10.1007/s004150050478. [DOI] [PubMed] [Google Scholar]
- 4.Basser LS. Benign paroxysmal vertigo of childhood. Brain. 1964;87:141–152. doi: 10.1093/brain/87.1.141. [DOI] [PubMed] [Google Scholar]
- 5.Watson P, Steele JC. Paroxysmal dysequilibrium in the migraine syndrome of childhood. Arch Otolaryngol. 1974;99:177–179. doi: 10.1001/archotol.1974.00780030185005. [DOI] [PubMed] [Google Scholar]
- 6.Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia. 1995;15:22–25. doi: 10.1046/j.1468-2982.1995.1501022.x. [DOI] [PubMed] [Google Scholar]
- 7.Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiat. 1979;42:363–367. doi: 10.1136/jnnp.42.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol. 2007;20:40–46. doi: 10.1097/WCO.0b013e328013f432. [DOI] [PubMed] [Google Scholar]
- 9.Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629–808. doi: 10.1177/0333102413485658. [DOI] [PubMed] [Google Scholar]
- 10.Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32:300–304. doi: 10.1111/j.1526-4610.1992.hed3206300.x. [DOI] [PubMed] [Google Scholar]
- 11.Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002;23:364–371. doi: 10.1097/00129492-200205000-00024. [DOI] [PubMed] [Google Scholar]
- 12.Cass SP, Ankerstjerne JKP, Yetiser S, Furman J, Balaban C, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106:182–189. doi: 10.1177/000348949710600302. [DOI] [PubMed] [Google Scholar]
- 13.Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000;110:1528–1534. doi: 10.1097/00005537-200009000-00022. [DOI] [PubMed] [Google Scholar]
- 14.Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56:436–441. doi: 10.1212/wnl.56.4.436. [DOI] [PubMed] [Google Scholar]
- 15.Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, Onal AE, Siva A. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012;13:147–157. doi: 10.1007/s10194-011-0414-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Neuhauser HK, von Brevern M, Radtke A, Lezius T, Feldmann M, Ziese T, Lempert T. Epidemiology of vestibular vertigo: a neurootological survey of the general population. Neurology. 2005;65:898–904. doi: 10.1212/01.wnl.0000175987.59991.3d. [DOI] [PubMed] [Google Scholar]
- 17.Neuhauser HK, Radtke A, von Brevern M, Feldman M, Lezius F, Ziese T, Lempert T. Migrainous vertigo. Prevalance and impact on quality of life. Neurology. 2006;67:1028–1033. doi: 10.1212/01.wnl.0000237539.09942.06. [DOI] [PubMed] [Google Scholar]
- 18.Cha YH, Santell LS, Baloh RW. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia. 2009;24:663–665. doi: 10.1111/j.1468-2982.2008.01770.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lee H, Sohn SI, Jung DK. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res. 2002;24:663–665. doi: 10.1179/016164102101200726. [DOI] [PubMed] [Google Scholar]
- 20.Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign paroxysmal vertigo. Ann Otol Rhinol Laryngol. 2000;109:377–380. doi: 10.1177/000348940010900407. [DOI] [PubMed] [Google Scholar]
- 21.Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Ménière’s disease Is there a link? Neurology. 2002;59:1700–1704. doi: 10.1212/01.wnl.0000036903.22461.39. [DOI] [PubMed] [Google Scholar]
- 22.Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: diagnostic challenge. Cephalalgia. 2004;24:83–91. doi: 10.1111/j.1468-2982.2004.00662.x. [DOI] [PubMed] [Google Scholar]
- 23.Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibularmigraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79:1607–1614. doi: 10.1212/WNL.0b013e31826e264f. [DOI] [PubMed] [Google Scholar]
- 24.Cuomo-Granston A, Drummond PD. Migraine and motion sickness: what is the link? Prog Neurobiol. 2010;91:300–312. doi: 10.1016/j.pneurobio.2010.04.001. [DOI] [PubMed] [Google Scholar]
- 25.Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W ID Migraine validation study. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61:375–382. doi: 10.1212/01.wnl.0000078940.53438.83. [DOI] [PubMed] [Google Scholar]
- 26.Siva A, Zarifoglu M, Ertas M, Saip S, Karli HN, Baykan B, Keskinaslan A, Senocak M. Validity of the ID-Migrane screener in the workplace. Neurology. 2008;70:1337–1345. doi: 10.1212/01.wnl.0000309221.85545.0d. [DOI] [PubMed] [Google Scholar]
- 27.Ertaş M, Baykan B, Tuncel D, Gökçe M, Gökçay F, Sirin H, Deniz O, Oztürk V, Idiman F, Karli N, Zarifoğlu M, Yildiz N, Siva A, Saip S, Göksan B, Ak F, Aluçlu U, Duman T, Melek IM, Bulut S, Berilgen S MIRA-3 Study Group. A comparative ID migraine screener study in ophthalmology. Cephalalgia. 2009;29:68–75. doi: 10.1111/j.1468-2982.2008.01702.x. [DOI] [PubMed] [Google Scholar]
- 28.Akdal G, Dönmez B, Öztürk V, Angın S. Is balance normal in migraineurs without history of vertigo? Headache. 2009;49:419–425. doi: 10.1111/j.1526-4610.2008.01256.x. [DOI] [PubMed] [Google Scholar]
- 29.Akdal G, Balcı BD, Angın S, Öztürk V, Halmagyi GM. A longitudinal study of balance in migraineurs. Acta Oto-Laryngologica. 2012;132:27–32. doi: 10.3109/00016489.2011.616532. [DOI] [PubMed] [Google Scholar]
- 30.Akdal G, Özge A, Ergör G. The prevalence of vestibular symptoms in migraine or tension-type headache. J Vestib Res. 2013;23:101–106. doi: 10.3233/VES-130477. [DOI] [PubMed] [Google Scholar]
- 31.von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128:365–74. doi: 10.1093/brain/awh351. [DOI] [PubMed] [Google Scholar]
- 32.Polensek SH, Tusa RJ. Nystagmus during attacks of vesti-bular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15:241–246. doi: 10.1159/000255440. [DOI] [PubMed] [Google Scholar]
- 33.von Brevern M. Oxford textbook of vertigo and imbalance. In: Bronstein AM, editor. Migraine and other episodic vestibular disorders. 1 Baskı. Oxford: Oxford University Press; 2013. pp. 231–239. [Google Scholar]
- 34.Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol. 2003;16:5–13. doi: 10.1097/01.wco.0000053582.70044.e2. [DOI] [PubMed] [Google Scholar]
- 35.Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2 + channel gene CACNL1A4. Cell. 1996;87:543–552. doi: 10.1016/s0092-8674(00)81373-2. [DOI] [PubMed] [Google Scholar]
- 36.Kim JS, Yue Q, Jen JC, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Genet. 1998;79:148–151. doi: 10.1002/(sici)1096-8628(19980901)79:2<148::aid-ajmg11>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- 37.von Brevern M, Ta N, Shankar A, Wiste A, Siegel A, Radtke A, Sander T, Escayg A. Migrainous Vertigo: Mutation Analysis of the Candidate Genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006;46:1136–1141. doi: 10.1111/j.1526-4610.2006.00504.x. [DOI] [PubMed] [Google Scholar]
- 38.Brantberg K, Baloh RW. Similarity of vertigo attacks due to Meniere’s disease and benign recurrent vertigo, both with and without migraine. Acta Otolaryngol. 2011;131:722–727. doi: 10.3109/00016489.2011.556661. [DOI] [PubMed] [Google Scholar]
- 39.Rassekh CH, Harker LA. The prevalence of migraine in Menière’s disease. Laryngoscope. 1992;102:135–138. doi: 10.1288/00005537-199202000-00006. [DOI] [PubMed] [Google Scholar]
- 40.Cha YH, Brodsjky, Ishiyama G, Sabatti C, Baloh RW. The relevance of migraine in patients with Méniere’s disease. Acta Oto-Laryngologica. 2007;127:1241–1245. doi: 10.1080/00016480701242469. [DOI] [PubMed] [Google Scholar]
- 41.Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007;130:2484–2493. doi: 10.1093/brain/awm126. [DOI] [PubMed] [Google Scholar]
- 42.Furman JM, Balaban CD, Jacob RG, Marcus DA. Migraine-anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry. 2005;76:1–8. doi: 10.1136/jnnp.2004.048926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lempert T, Neuhauser H, Daroff RB. Vertigo as a symptom of migraine. Ann N Y Acad Sci. 2009;1164:242–251. doi: 10.1111/j.1749-6632.2009.03852.x. [DOI] [PubMed] [Google Scholar]
- 44.Fotuhi M, Glaun B, Quan SY, Sofare T. Vestibular migraine: a critical review of treatment trials. J Neurol. 2009;256:711–716. doi: 10.1007/s00415-009-5050-5. [DOI] [PubMed] [Google Scholar]
- 45.Munhoz RP, Werneck LC, Teive HAG. The differential diagnosis of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics. Clin Neurol Neurosurg. 2010;112:431–435. doi: 10.1016/j.clineuro.2010.03.003. [DOI] [PubMed] [Google Scholar]
- 46.Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: A pilot randomized placebo-controlled trial. Neurology. 2003;60:882–883. doi: 10.1212/01.wnl.0000049476.40047.a3. [DOI] [PubMed] [Google Scholar]
